Get the Stockscreener App
6.4489
5.50%
-0.3711
Aquestive Therapeutics Inc stock is traded at $6.4489, with a volume of 2.72M.
It is down -5.50% in the last 24 hours and up +11.12% over the past month.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
See More
Previous Close:
$6.82
Open:
$6.78
24h Volume:
2.72M
Relative Volume:
0.98
Market Cap:
$643.22M
Revenue:
$58.36M
Net Income/Loss:
$-25.72M
P/E Ratio:
-17.71
EPS:
-0.3641
Net Cash Flow:
$-24.91M
1W Performance:
-7.93%
1M Performance:
+11.12%
6M Performance:
+114.83%
1Y Performance:
+16.76%
1-Day Range:
$6.16
$6.79
1-Week Range:
$6.16
$7.05
52-Week Range:
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Name
Aquestive Therapeutics Inc
Sector
Phone
908-941-1900
Address
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
6.45 | 825.04M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
144.22 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.43 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.385 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.06 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Piper Sandler | Overweight |
| Mar-28-24 | Initiated | Raymond James | Outperform |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Apr-22-19 | Initiated | H.C. Wainwright | Buy |
| Jan-03-19 | Initiated | Lake Street | Buy |
| Aug-20-18 | Initiated | JMP Securities | Mkt Outperform |
| Aug-20-18 | Initiated | RBC Capital Mkts | Outperform |
View All
Aquestive Therapeutics Inc Stock (AQST) Latest News
Why Aquestive Therapeutics Inc. stock is favored by pension funds2025 EndofYear Setup & AI Enhanced Execution Alerts - newser.com
How to monitor Aquestive Therapeutics Inc. with trend dashboardsProduct Launch & Reliable Entry Point Alerts - newser.com
Using R and stats models for Aquestive Therapeutics Inc. forecastingMarket Sentiment Review & Weekly Hot Stock Watchlists - newser.com
Using AI based signals to follow Aquestive Therapeutics Inc.2025 Market WrapUp & Growth Focused Stock Reports - newser.com
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler - GlobeNewswire
Aquestive Therapeutics Inc. stock momentum explainedPortfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com
Is Aquestive Therapeutics Inc. stock attractive for retirement portfoliosJuly 2025 Levels & Verified Swing Trading Watchlist - newser.com
Predicting Aquestive Therapeutics Inc. trend using moving averagesWeekly Stock Recap & Stepwise Trade Signal Guides - newser.com
Why Aquestive Therapeutics Inc. stock is trending among retail traders2025 Retail Activity & Real-Time Stock Entry Alerts - newser.com
Risk vs reward if holding onto Aquestive Therapeutics Inc.2025 Volume Leaders & Intraday High Probability Setup Alerts - newser.com
Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Trade Performance Summary & Precise Buy Zone Tips - newser.com
Will Aquestive Therapeutics Inc. stock gain from strong economyWeekly Profit Summary & Weekly High Potential Stock Alerts - newser.com
Will Aquestive Therapeutics Inc. bounce back from current supportWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Why Aquestive Therapeutics Inc. stock could outperform in 2025Market Movement Recap & Expert Verified Movement Alerts - newser.com
Long term hold vs stop loss in Aquestive Therapeutics Inc.Weekly Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
What Wall Street predicts for Aquestive Therapeutics Inc. stock price2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com
Can Aquestive's Oral, Non-Device Epinephrine Film Capture A Share Of The Growing U.S. Market? - RTTNews
Detecting support and resistance levels for Aquestive Therapeutics Inc.Weekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Real time alert setup for Aquestive Therapeutics Inc. performanceJuly 2025 Short Interest & AI Driven Stock Reports - newser.com
Volatility clustering patterns for Aquestive Therapeutics Inc.Share Buyback & High Accuracy Trade Alerts - newser.com
Can technical indicators confirm Aquestive Therapeutics Inc.’s reversalChart Signals & Stepwise Swing Trade Plans - newser.com
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting - The Manila Times
Aquestive Therapeutics Inc. stock chart pattern explainedMarket Risk Report & Real-Time Market Trend Scan - newser.com
Aquestive Therapeutics Inc Stock (AQST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):